REQUEST A DEMO
Total
USD $0.00
Search more companies

Baekje Pharmaceutical Co., Ltd. (South Korea)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Baekje Pharmaceutical Co., Ltd. Profile Updated: November 23, 2021
Buy our report for this company USD 29.95 Most recent financial data: 2020 Available in: English Download a sample report

Baekje Pharmaceutical Co., Ltd. is engaged in distribution of pharmaceutical products. The company is based in Mokpo, South Korea. Baekje Pharmaceutical Co., Ltd. was incorporated in 1971.

Headquarters
Samil-ro Mokpo-si Jeonnam, 11
Mokpo; Jeollanam;

Contact Details: Purchase the Baekje Pharmaceutical Co., Ltd. report to view the information.

Website: http://www.baekje.net

Basic Information
Total Employees:
Purchase the Baekje Pharmaceutical Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Baekje Pharmaceutical Co., Ltd. report to view the information.
Registered Capital:
Purchase the Baekje Pharmaceutical Co., Ltd. report to view the information.
Ratings:
Purchase the Baekje Pharmaceutical Co., Ltd. report to view the information.
Incorporation Date:
April 01, 1964
Key Executives
Purchase this report to view the information.
Chairman
Ownership Details
Purchase this report to view the information.
30%
Purchase this report to view the information.
17.6%
Purchase this report to view the information.
16.8%
Subsidiaries
P&P21 Co.,Ltd.
79%
Pharm Road Co.,Ltd.
17.9%
Chodang Industrial Co.,Ltd.
Company Performance
Financial values in the chart are available after Baekje Pharmaceutical Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
33.87%
Total operating revenue
33.87%
Operating profit (EBIT)
40.39%
EBITDA
10.52%
Net Profit (Loss) for the Period
70.42%
Total assets
5.62%
Total equity
17.61%
Operating Profit Margin (ROS)
0.02%
Net Profit Margin
0.08%
Return on Equity (ROE)
1.83%
Debt to Equity Ratio
-21.73%
Quick Ratio
-0%
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?